4.7 Article

The influence of embryo stage on obstetric complications and perinatal outcomes following programmed compared to natural frozen-thawed embryo transfer cycles: a systematic review and meta-analysis

期刊

FRONTIERS IN ENDOCRINOLOGY
卷 14, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2023.1186068

关键词

frozen-thawed embryo transfer; programmed cycle; natural cycle; embryo; embryo at time of transfer

向作者/读者索取更多资源

A systematic review and meta-analysis found that the stage of embryo transfer had a significant impact on obstetric and perinatal outcomes in programmed frozen-thawed embryo transfer (FET) and natural FET cycles. Programmed FET cycles had higher risks of hypertensive disorders of pregnancy, gestational hypertension, preeclampsia, gestational diabetes mellitus, large for gestational age, macrosomia, preterm delivery, placenta previa, postpartum haemorrhage, and preterm premature rupture of membranes compared to natural FET cycles with overall embryo transfer and blastocyst transfer. However, there were no clear differences in outcomes between programmed FET cycles and natural FET cycles with cleavage-stage embryo transfer.
Objective: To investigate the effect of embryo stage at the time of transfer on obstetric and perinatal outcomes in programmed frozen-thawed embryo transfer (FET) versus natural FET cycles. Design: Systematic review and meta-analysis. Setting: Not applicable. Patient(s): Women with programmed frozen-thawed embryo transfer (FET) and natural FET. Intervention(s): The PubMed, MEDLINE, and EMBASE databases and the Cochrane Central Register of Controlled Trials (CCRT) were searched from 1983 to October 2022. Twenty-three observational studies were included. Primary outcome measure: The primary outcomes were hypertensive disorders of pregnancy (HDPs), gestational hypertension and preeclampsia (PE). The secondary outcomes were gestational diabetes mellitus (GDM), placenta previa, postpartum haemorrhage ( PPH), placental abruption, preterm premature rupture of membranes (PPROM), large for gestational age (LGA), small for gestational age (SGA), macrosomia, and preterm delivery (PTD). Result(s): The risk of HDP (14 studies, odds ratio (OR) 2.17; 95% confidence interval (CI) 1.95-2.41; P<0.00001; I-2 = 43%), gestational hypertension (11 studies, OR 1.38; 95% CI 1.15-1.66; P=0.0006; I-2 = 19%), PE (12 studies, OR 2.09; 95% CI 1.88-2.32; P<0.00001; I-2 = 0%), GDM (20 studies, OR 1.09; 95% CI 1.02-1.17; P=0.02; I-2 = 8%), LGA (18 studies, OR 1.11; 95% CI 1.07-1.15; P<0.00001; I-2 = 46%), macrosomia (12 studies, OR 1.15; 95% CI 1.07-1.24; P=0.0002; I-2 = 31%), PTD (22 studies, OR 1.21; 95% CI 1.15-1.27; P<0.00001; I-2 = 49%), placenta previa (17 studies, OR 1.2; 95% CI 1.02-1.41; P=0.03; I-2 = 11%), PPROM (9 studies, OR 1.19; 95% CI 1.02-1.39; P=0.02; I-2 = 40%), and PPH (12 studies, OR 2.27; 95% CI 2.02-2.55; P <0.00001; I-2 = 55%) were increased in programmed FET cycles versus natural FET cycles with overall embryo transfer. Blastocyst transfer had a higher risk of HDP (6 studies, OR 2.48; 95% CI 2.12-2.91; P<0.00001; I-2 = 39%), gestational hypertension (5 studies, OR 1.87; 95% CI 1.27-2.75; P=0.002; I-2 = 25%), PE (6 studies, OR 2.23; 95% CI 1.93-2.56; P<0.00001; I-2 = 0%), GDM (10 studies, OR 1.13; 95% CI 1.04-1.23; P=0.005; I-2 = 39%), LGA (6 studies, OR 1.14; 95% CI 1.07-1.21; P<0.0001; I-2 = 9%), macrosomia (4 studies, OR 1.15; 95% CI 1.05-1.26; P<0.002; I-2 = 68%), PTD (9 studies, OR 1.43; 95% CI 1.31-1.57; P<0.00001; I-2 = 22%), PPH (6 studies, OR 1.92; 95% CI 1.46-2.51; P<0.00001; I-2 = 55%), and PPROM (4 studies, OR 1.45; 95% CI 1.14-1.83; P=0.002; I-2 = 46%) in programmed FET cycles than in natural FET cycles. Cleavage-stage embryo transfers revealed no difference in HDPs (1 study, OR 0.81; 95% CI 0.32-2.02; P=0.65; I-2 not applicable), gestational hypertension (2 studies, OR 0.85; 95% CI 0.48-1.51; P=0.59; I-2 = 0%), PE (1 study, OR 1.19; 95% CI 0.58-2.42; P=0.64; I(2)not applicable), GDM (3 study, OR 0.79; 95% CI 0.52-1.20; P=0.27; I-2 = 21%), LGA (1 study, OR 1.15; 95% CI 0.62-2.11; P=0.66; I(2)not applicable), macrosomia (1 study, OR 1.22; 95% CI 0.54-2.77; P=0.64; I-2 not applicable), PTD (2 studies, OR 1.05; 95% CI 0.74-1.49; P=0.79; I-2 = 0%), PPH (1 study, OR 1.49; 95% CI 0.85-2.62; P=0.17; I(2)not applicable), or PPROM (2 studies, OR 0.74; 95% CI 0.46-1.21; P=0.23; I-2 = 0%) between programmed FET cycles and natural FET cycles. Conclusion(s): The risks of HDPs, gestational hypertension, PE, GDM, LGA, macrosomia, SGA, PTD, placenta previa, PPROM, and PPH were increased in programmed FET cycles versus natural FET cycleswith overall embryo transfer and blastocyst transfer, but the risks were not clear for cleavage-stage embryo transfer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据